Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Phase 2 RCT in The Lancet : at 24 weeks, tesofensine 0.5 mg produced a mean diet-adjusted weight loss of 9.2%, and at 1.0 mg a loss of 10.6%, compared with 2.0% for diet plus placebo (p 99% (HPLC, LCMS) Documentation: Batch-specific Certificate of Analysis (COA) included Handling for Research Use Tesofensine capsules ship as a pre-encapsulated, dry oral-research format
doi: 10.17925/EE.2022.18.1.10
IDUN upholds a stricter 99% purity standard of its own
Yes, both agents improve insulin sensitivity and lower glucose levels, so combining them may increase hypoglycemia risk, especially in patients taking additional diabetes medications
IV therapy delivers even higher doses directly where your liver needs them most
US$ 21.11
US$ 20.42
US$ 28.30
US$ 21.55
US$ 21.98
US$ 28.59
US$ 19.99
US$ 24.26
